Abstract
ObjectivesThe study aimed to compare early molecular response (EMR) rates at 3 months of imatinib therapy with and without vitamin D3 supplementation in patients newly diagnosed with chronic-phase chronic myeloid...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have